• Profile
Close

Portal venous pulsatility index: A novel biomarker for diagnosis of high-risk nonalcoholic fatty liver disease

American Journal of Roentgenology Jan 23, 2020

Baikpour M, Ozturk1 A, Dhyani M, et al. - In this study, the accuracy of portal vein pulsatility for noninvasive diagnosis of high-risk nonalcoholic fatty liver disease (NAFLD) was measured. Researchers designed a retrospective study involving individuals with a biopsy-proven diagnosis of NAFLD who underwent a Duplex Doppler ultrasound assessment of the main portal vein within 1 year of liver biopsy between January 2014 and February 2018. They reviewed doppler ultrasound images. They enrolled 123 participants. Thirty-three out of 123 participants had high-risk NAFLD and were found to have a lower venous pulsatility index (VPI) than the other 90 participants. For high-risk NAFLD VPI, they noted that NAFLD FS, FIB-4, and APRI had statistically significant diagnostic values. VPI was noted as the highest optimism-corrected AUC. VPI can be considered as an accurate noninvasive biomarker for the diagnosis of high-risk NAFLD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay